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NEURAL RECOVERY AFTER CORTICAL INJURY: EFFECTS OF MSC 
DERIVED EXOSOMES IN THE CERVICAL SPINAL CORD 
SAMANTHA MARIE CALDERAZZO 
ABSTRACT 
Stroke is the leading cause of long-term disability costing the United States (US) health 
care system 34 billion dollars. However, stem cell based therapies have been shown to 
improve recovery after cortical injury by enhancing neural recovery and modulating 
immune responses (Lambertsen, Finsen, & Clausen, 2018; Orczykowski et al., 2018; 
Stonesifer et al., 2017). Specifically, reorganization of the motor circuit at the level of the 
spinal cord has been shown to improve functional recovery after injury (Christoph 
Wiessner; Weidner et al., 2001; Lee et al., 2004; Zai et al., 2009).  In our study we used a 
non-human primate (NHP) model to study the neural recovery after cortical injury similar 
to damage from an ischemic stroke in the motor cortex with or without a systemic 
treatment of mesenchymal stem cell derived (MSCd) exosomes. We find a robust 
recovery in motor function within the first few weeks after injury including improved 
grasp patterns and faster retrieval times during behavioral tasks. Additionally, assessment 
of the cervical spinal cord (CSC) reveals decreased levels of sprouting axons from 
ipsilesional corticospinal tract (CST) and MAP2+ synapses in the contralesional ventral 
horn at 14 weeks post-injury, which correlates with improved retrieval latencies. We 
hypothesize that MSCd exosomes may encourage an earlier switch to anti-inflammatory 
and repair processes that reduces secondary damage in the cortex resulting in earlier 
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pruning of axon collaterals and reducing the need for compensatory mechanisms of the 
spinal cord at 14 weeks post injury.  
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INTRODUCTION 
Every year, over 795,000 people in the United States experience a stroke, of which 
140,000 will die, while others are suffer from long-term disability. Specifically, stroke is 
the leading cause of serious long-term disability and permanently reduces mobility in 
over half of stroke survivors resulting in 34 billion dollars of health care services, 
treatments, and missed days of work (AHA stroke.org). The vast majority (87%) of 
strokes are caused by clots resulting in ischemia and the only FDA approved treatments 
for ischemic stroke are either tissue plasminogen activator (tPA) to break up clots 
(Koroshetz, 1996) or surgical interventions to remove the clots. Unfortunately, these 
treatments must be given within 3-4 hours of onset to be effective and a majority of 
ischemic stroke patients do not arrive to the hospital in time to receive this treatment 
(Leon-Jimenez et al., 2014; Saver et al., 2013). Although time since stroke onset is an 
important factor for improved outcome, physical rehabilitation during the recovery period 
has been demonstrated to facilitate recovery of function in the first four weeks after 
stroke (Grefkes and Ward, 2014). However, according to the National Stroke Association 
only 10 percent of stroke patients (https://www.stroke.org/) make a full recovery leaving 
the remainder of patients with minor to severe impairments in their daily lives.  
Research investigating the type of cortical injury that occurs following stroke reveals that 
blockage of normal blood flow into the brain results in an “ischemic cascade” (Brouns 
and De Deyn, 2009). Specifically, depletion of ATP leads to oxidative phosphorylation, 
apoptosis, and increased reactive oxygen species (ROS), while disruption of ion channels 
produces protein degradation and mitochondrial damage (Lipton, 1999). In response, 
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microglia and peripheral immune cells are recruited to the site to release pro-
inflammatory cytokines (Patel et al., 2013; Fumagalli et al., 2015), which further 
promotes reactive astrocytes. Eventually, astrocytes will form a glial scar around the 
lesion to reduce secondary injury and microglia will clear cellular debris to allow for 
regrowth (Fumagalli et al., 2015). As inflammation resolves, surviving neurons in the 
penumbra and surrounding cortical areas begin to reorganize in conjunction with 
angiogenesis resulting in some degree of functional recovery after injury (Carmichael, 
2003; Nudo, 2007, Brown et al., 2007).  
As of now there are no approved treatments to enhance the innate molecular recovery 
processes that occur after stroke, such as neurorestorative therapeutics or inflammatory 
modulators that promote cortical reorganization. However, enhanced recovery after 
cortical injury has been reported with investigational cell based therapies. (Lambertsen, 
Finsen, & Clausen, 2018; Orczykowski et al., 2018; Stonesifer et al., 2017). We and 
others have revealed that stem cell based therapies reduce inflammation and enhance 
plasticity (Chopp, Li, & Zhang, 2009; Lakhan et al., 2009; Mahmood, Lu, Qu, Goussev, 
& Chopp, 2005; Stonesifer et al., 2017; Xiong et al., 2011; Jeong et al., 2014; Liu et al., 
2010). It is hypothesized that the effect of these therapeutic cells is mainly from released 
signals, such as growth factors and cytokines initiating repair (Smith et al., 2012; Aleynik 
et al., 2014; Marei et al., 2018).  Taking this one step further, we have found that 
mesenchymal stem cells (MSC) release endosome derived microvesicles, known as 
exosomes, containing microRNAs (miRNA) and proteins that appear to promote both 
functional recovery and plasticity in a rodent model. (Katakowski et al., 2013; Xin et al., 
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2012). To further test the efficacy of these MSCs derived exosomes we have 
administered them intravenously in our non-human primate (NHP) model 24 hours and 
14 days after cortical injury. This treatment resulted in significant functional recovery 
within the first few weeks after the injury including a return to pre-injury retrieval 
latencies and rescued grasp patterns compared to untreated monkeys.  
Since treated NHPs in this study recovered so robustly within the first few weeks and 
exosomes were administered systemically, we began to investigate the potential 
mechanisms underlying the action of the exosomes. Particularly, studies have shown that 
compensatory mechanisms in the spinal cord can be involved in recovery of motor 
function after injury, such as axonal sprouting in corticospinal tracts (CST) from either 
contralesional or ipsilesional tracts. The sprouting in these long-range pathways can 
produce more synapses in the ventral horn to compensate for damaged axons (Wiessner 
et al, 2003; Weidner et al., 2001; Lee et al., 2004; Zai et al., 2009). Hence, this project 
focused on investigating the role of axonal sprouting and synaptic plasticity in the 
cervical spinal cord of MSC derived (MSCd) exosome treated NHPs and its association 
with motor function.     
METHODS 
Subjects: Ten female rhesus monkeys (macaca mulatta) ranging from 16 – 26 years of 
age (approximately equivalent to 48 and 78 year old humans; Tigges et al., 1988) were 
obtained from the National Primate Research Facilities or Private Vendors and had 
known birthdates with complete health records (Table 1). Monkeys received medical 
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examinations and magnetic resonance imaging to ensure there was no occult health 
problems or neurological damage. Monkeys were housed in the Animal Science Center 
of Boston University School of Medicine which is AAALAC accredited. All procedures 
were approved by the Boston University Institutional Animal Care and Use Committee.   
Table 1: Subject List. Details on subjects used for this study. 
Animal Group Age Weight Sex 
AM320 Exosomes 21.83 11.4 F 
AM332 Exosomes 24.08 12.1 F 
AM338 Exosomes 16.42 6.1 F 
SM061 Exosomes 21.75 6.2 F 
SM062 Exosomes 20.92 8.2 F 
AVERAGE  21 8.8  
AM323 Control 23.67 11 F 
AM331 Control 26.08 13.1 F 
AM335 Control 20.33 9.5 F 
AM337 Control 24.33 7 F 
AM339 Control 21.42 10.3 F 
AVERAGE  23.166 10.18  
 
Pre-operative Training on Fine Motor Function Testing 
As described in detail previously (Moore, Killiany, Pessina, Moss, & Rosene, 2010; 
Moore et al., 2016), monkeys were trained on a task of fine motor function of the hand, 
the Hand Dexterity Task (HDT), using a testing apparatus that controls, quantifies and 
video records responses from each hand. Using this apparatus, monkeys were trained on 
the HDT for a total of 12 days (Monday, Wednesday and Friday each week for 4 weeks). 
The HDT is a modified version of a Klüver board (Kluver, 1935) and requires precise 
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control of the digits, particularly apposition of the thumb and index finger, to retrieve a 
small, visible food reward (M&M’s, Mars, Inc) from two different size round wells in a 
Plexiglas tray. Food rewards were round and approximately 1cm in diameter. Both wells 
were 1 cm deep. The large well was 25 mm wide and the small well was 18 mm wide. 
Time to retrieve the food reward is recorded by a timer that is connected to photocells 
that are located in the openings on each side of the apparatus. The timer starts when the 
monkey puts a hand through one of the openings, triggering the photocells to start the 
timer. The timer stops when the monkey removes his hand. An experimenter records 
whether or not the reward was successfully retrieved and the response time to retrieve is 
recorded. Each test day consists of 16 trials for each of the two well sizes as well as for 
each hand resulting in a total of 32 trials. The order of trials for each hand and well 
follows a pseudorandom balanced sequence to eliminate any order effects. Monkeys are 
given 30 seconds to complete a trial. If they do not or would not complete a trial in 30 
sec, the trial is terminated and the monkey is given one additional opportunity to 
complete that trial. After a second failed attempt, a non-response is recorded, the 
monkey’s difficulties are noted in the study record and the next trial is initiated.  
Hand Preference 
At the completion of pre-training on the HDT, free choice trials with both sides of the 
apparatus baited and accessible are administered to determine which hand is “preferred”. 
This assessment is also compared with the pre-operative acquisition rates for each hand. 
Based on this assessment, the cortical injury is targeted to the hand representation of the 
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hemisphere controlling the preferred hand to ensure that monkeys are motivated to use 
the impaired hand during post-operative testing. 
Group Assignment and Blinding 
After the completion of pre-training, the monkeys were randomly assigned in a balanced 
fashion based on weight and age to receive either the experimental exosome treatment or 
vehicle/placebo. All study personnel (surgeons, technicians, behavioral testers, etc.) were 
kept blind to the assignment during surgery and all post-operative in-vivo procedures, 
testing and terminal brain tissue harvest and processing. 
Electrophysiological Mapping of the Hand Representation in Motor Cortex 
All surgical procedures were carried out under aseptic conditions. Each monkey was 
anesthetized with intravenous sodium pentobarbital (15-25 mg/kg) to effect, and 
antibiotics and analgesics were given prior to and during surgery. Many anesthetics are 
known to differentially affect cortical excitability and this could potentially impact 
cortical mapping, the extent of damage that occurs and recovery of function. For our 
surgical procedure, we use sodium pentobarbital as the anesthesia as it has limited effect 
on cortical injury and allows for motoric responses to be elicited during the electrical 
stimulation to map the motor cortex. Heart rate, respiration, temperature, blood 
oxygenation and muscle tonus were monitored to ensure physiological homeostasis and a 
safe surgical level of anesthesia. The head was stabilized in a stereotactic apparatus, and a 
midline incision was made followed by reflection of the temporalis muscle. A bone flap 
approximately 40mm in anterior to posterior extent and 35 mm in medial to lateral extent 
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was made centered over the frontal and parietal lobes. The bone was removed in one 
piece for later replacement. The dura was incised to expose the pre-central sulcus and 
primary motor cortex.  
To create reproducible cortical injury and motor deficits, a calibrated photograph of the 
pre-central gyrus was taken and printed. The precentral gyrus was then systematically 
explored using electrical stimulation delivered through a small monopolar silver ball 
electrode placed gently on the surface of the pia to evoke movements.  A surface 
electrode was used rather than a sharp electrode that could penetrate the cortex in order to 
avoid extraneous damage to the motor cortex outside the hand representation.  
Stimulation sites were spaced 2 mm apart (anterior to posterior) in rows and each row 
was separated from the next by 2 mm (ventral to dorsal). The stimulating electrode was 
moved across the precentral gyrus systematically in rows spaced approximately 2mm 
apart (anterior to posterior) and separated from the next row by approximately 2mm 
(medial to lateral) as shown in Fig. 1.  Monopolar stimulus pulses of 250 µsec duration at 
amplitudes from 2.0 to 3.0 mA were delivered at each site once every 2 seconds first 
singly and then in a short train of 4 pulses at a rate of 100 Hz. Non-responsive sites were 
further tested with a 200 Hz train consisting of 4 or 8 pulses of 2 msec duration. During 
each stimulation, a trained observer noted muscle movements (eg. distinct movement or 
twitches of muscle) in specific areas of the digits, hand, forearm or arm, both visually and 
by palpation.  The intensity of the motor response in the hand and digits was graded on a 
scale of 1 to 3 (barely visible to maximal). Specific stimulation sites with the lowest 
threshold and highest motor response were marked on the calibrated photograph creating 
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a cortical surface map of the hand area that was used to guide placement of the lesion. 
(Fig. 1).   
Figure 1: Methodology. Photographs showing the stimulation sites on the hand 
representation maps (A,D), the intraoperative lesions (B,E) and final lesion after 
perfusion (C,F) for a monkey that received vehicle control (top row) and one that 
received exosomes (bottom row). Black circles represent sites that generated a 
positive response in the hand or digits while white circles did not generate a positive 
response. Scale bar = 5mm. CS=Central Sulcus.
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Placement of Selective Cortical Injury 
Using the map described above, cortical injury was induced by making a small incision in 
the pia at the dorsal limit of the mapped representation. A small glass suction pipette was 
then inserted under the pia and used to bluntly transect the small penetrating arterioles as 
they enter the underlying cortex. Suction and irrigation with sterile saline were sufficient 
to stanch any bleeding and maintain a clear field.  Since the hand representation is known 
to extend down the rostral bank of the central sulcus, the sulcus was then opened down to 
the fundus along the length of the gyral hand representation by microdissection with a 
small glass pipette and a blunt periosteal elevator, taking care to leave the somatosensory 
areas on the caudal bank intact. The pia was then dissected with the glass pipette all the 
way down to the fundus of the sulcus. The hand area in the sulcus was not 
electrophysiologically mapped with the electrode to avoid inadvertent damage to the 
somatosensory areas on the caudal bank of the central sulcus as this mapping requires 
prolonged retraction. However, we have verified in terminal experiments the presence of 
the hand representation on the rostral bank. This pial dissection of penetrating vessels 
removes the blood supply to the cortex of the hand representation, inducing damage that 
extends down to the underlying white matter.  
After the lesion was made and any bleeding stopped, the dura was closed, the bone flap 
was sutured back in place using small burr holes placed in the flap and the muscles, 
fascia and skin were closed in layers. Immediately following surgery, antibiotics and 
analgesics were administered and the monkey was kept in an incubator and monitored 
continuously until anesthesia wore off. For the next 3-7 days (or as needed) monkeys 
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were given analgesics and monitored regularly for any signs of infection or 
complications. 
Exosome Preparation and Administration 
Exosomes were extracted from MSCs harvested from the bone marrow of a young adult 
monkey. Bone marrow was extracted from the head of the humerus or the iliac crest 
according to the following protocol. Monkeys were sedated with Ketamine (10mg/kg, 
IM) and then anesthetized with sodium pentobarbital (15-25 mg/kg IV). The area over the 
bone was shaved and sterilized, a sterile drape was placed over the area and a small (1-
2cm) incision was made over the bone site. A Jamshidi Bone Marrow Biopsy Needle 
(Care Fusion, Vermont Hills, IL) was advanced through the incision into the bone. Once 
the needle was advanced to the correct position, the lancet was removed and a syringe 
attached and the sample was extracted. Once the needle was removed, sutures were 
placed to close the incision. The monkey was treated with Buprenex (0.01-0.03mg/kg). 
The extracted bone marrow was mixed with 10-15% anticoagulant citrate dextrose 
(ACD-A) and shipped on ice from Boston University School of Medicine to Henry Ford 
Health System for same day delivery. 
Once received, bone marrow was centrifuged at 4,000 × g for 15 minutes to separate 
blood components. The buffy coat, which contains mononuclear cells and resides 
between the lighter plasma fraction and the heavier erythrocyte fraction after 
centrifugation, was removed by careful pipetting. It was then washed once in culture 
medium and plated into T75 flasks in alpha-MEM with 20% FBS. Cells were grown to 
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confluence and passaged as necessary. To grow sufficient numbers of exosomes, ten 
million (10 × 106) cells were seeded into a Quantum incubator (Terumo BCT, 
Lakewood, CO) and were grown in alpha-MEM containing 10% exosome depleted FBS 
circulated through fibronectin coated hollow fibers. Media were harvested starting on day 
three, followed by every other day for 4 days, and then every day for 2 days. Exosomes 
were isolated from the cell culture media via multistep centrifugation at 4°C, as 
previously described (Y. Zhang et al., 2015; Y. Zhang et al., 2017), with slight 
modification. Briefly, the cell culture media were centrifuged at 250 × g for 5 minutes, 
and then the supernatants removed and centrifuged at 3,000 × g for 30 minutes, followed 
by filtration through a 0.22μm filter (SLMP025SS; EMD Millipore Corporation, 
Billerica, MA). The resulting media were then centrifuged at 100,000 × g for 2 hours to 
pellet exosomes, which were resuspended in phosphate-buffered saline and stored at 4°C. 
Exosome concentration was measured using a qNano (Izon, Cambridge, MA). 
Treatments were prepared at a concentration of 4 x 1011 particles/kg. 
Exosome concentration was determined on an Izon qNano particle counter, and the 
concentration was adjusted so that each of the randomly assigned treated monkeys 
received 4 x 1011 particles/kg in 10mL of PBS administered intravenously 24 hours and 
again 14 days after cortical injury. Dosing was determined based on our rodent studies. 
(Xin, Li, Cui, et al., 2013; Y. Zhang et al., 2017) The remaining monkeys received 
infusions of PBS intravenously 24 hours and again 14 days after cortical injury. Dosing 
was determined based on preliminary studies in rodents (Xin, Li, Cui, et al., 2013). 
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Exosomes and Vehicle were administered intravenously while the monkeys were sedated 
with Ketamine (10mg/Kg, IM). 
Initial Cage-Side Post-operative Assessment 
Beginning immediately after recovery from surgery and continuing for 14 days, the upper 
extremity motor function of each monkey was rated daily in its home cage. Both upper 
limbs were rated for level of function in terms of tone, tremor, fine motor function of the 
hand, strength of the hand, digit flexion as well as movements of the forearm, wrist, arm 
and shoulder using our NHP Upper Extremity Motor Dysfunction Assessment Scale.   
Post-operative Testing 
Post-operative testing on the HDT began two weeks after surgery and continued for 12 
weeks. Testing on the HDT was conducted on Monday, Wednesday and Friday of each 
week. Seventy percent of the trials required the use of the impaired hand, while 30% 
were given to the intact hand. The 30% of trials given to the unimpaired hand provide 
sufficient rewards to maintain motivation and sufficient data to demonstrate that effects 
are not due to generalized changes in motivation or motor function. Each animal was 
given 30 seconds to complete a trial as in pre-operative training. The forced use of the 
impaired hand on 70% of the trials is similar in nature to constraint-induced therapy used 
in human rehabilitation which forces use of the impaired limbs. (Corbetta, Sirtori, 
Castellini, Moja, & Gatti, 2015; Kwakkel et al., 2016; Souza, Conforto, Orsini, Stern, & 
André, 2015) Testing continued for 12 weeks, the time estimated for monkeys receiving 
placebo to achieve asymptotic stable performance. 
13 
 
Grasp Pattern Assessment 
While some spontaneous recovery does occur after injury to cortical motor areas 
controlling the hand and digits, full recovery of digit function is rare. Further, the 
spontaneous recovery that does occur is compensatory in nature and not a complete 
return to pre-injury fine motor function (Hylin, Kerr, & Holden, 2017). The distinction 
between complete and compensatory recovery is important for assessing new treatments 
for stroke and cortical injury as the development of compensatory movements falls short 
of full functional use and hence limits normal activities of daily living (Levin, Kleim, & 
Wolf, 2009; Lum et al., 2009).  Therefore, we developed our Non-Human Primate Grasp 
Assessment Scale (GRAS) to detect and quantify significant impairments in fine motor 
function of the hand and to evaluate recovery of function of individual digits and precise 
finger-thumb pinch used by monkeys to retrieval of food morsels to distinguish between 
compensatory grasp function and a return to pre-injury grasp patterns.  
To apply our scale to the performance of the monkeys, performance on the HDT during 
pre-operative training and post-operative testing was recorded with fixed placement 
cameras (Logitech, Newark, CA). A licensed Occupational Therapist (Monica Pessina) 
who has clinical experience in the treatment of patients with upper extremity impairment 
following stroke, and a trained research technician (Bethany Bowley) analyzed the 
videotapes using our NHP Grasp Assessment Scale. This scale was adapted from the 
Eshkol-Wachman Movement Notation (Carr, Shepherd, Nordholm, & Lynne, 1985; 
Whishaw et al., 2002) and the Fugl-Meyer Motor Assessment scale. (Fugl-Meyer, Jaasko, 
Leyman, Olsson, & Steglind, 1975)  Our scale rates the position of the digits during grasp 
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and the pattern of grasp and release to provide a semi-quantitative measure of maturity of 
the grasp pattern. The scale includes 8 divided hierarchical stages, for a total of 14 units 
with the maximum score of 8 reflecting normal grasp patterns (functional pinch between 
thumb and one individual digit).  
Tissue Collection and Preparation 
For perfusion-fixation of the central nervous system (CNS), monkeys were sedated with 
Ketamine (10 mg/kg IM) deeply anesthetized with sodium pentobarbital (25 mg/kg IV to 
effect) and were euthanized by exsanguination during transcardial perfusion-fixation of 
the CNS. First, 5 minutes of cold Krebs-Heinsleit buffer (4°C, pH 7.4) was perfused and 
fresh tissue biopsies were obtained. This was followed immediately with 8 liters of warm 
4% paraformaldehyde, (30°C, pH 7.4) over 10 minutes. The brain was blocked, in situ, in 
the coronal plane to ensure reproducible planes of section during later processing and 
then removed from the skull. The cervical spinal cord was removed from the vertebral 
column and cut with a 45 degree angle to denote rostral from caudal and notched on the 
contralesional side for later processing. Tissue was post-fixed overnight in 4% 
paraformaldehyde (no more than 18 hours). It was then transferred to cryoprotectant 
solution to eliminate freezing artifact. Cryoprotected blocks were flash frozen at -75°C 
and stored at -80°C. Brain tissue was cut on a microtome in dry ice into interrupted series 
of coronal sections (eight series of 30 μm thick sections and one 60 μm thick series) with 
a 300um spacing between sections within a series of 30 μm. The 60 μm series was 
immediately mounted on microscope slides and stained with thionin for lesion 
reconstruction. The other series were collected in phosphate buffer with 15% glycerol 
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and stored at -80°C. Spinal cord tissue was also cut on a microtome in dry ice into 
interrupted series of transverse sections (12 series of 40um thick sections) with a 480um 
spacing between sections. One series was immediately mounted on microscope slides and 
stained with thionin. Other series were collected in phosphate buffer with 30% sucrose 
and stored at -20 degrees. 
Immunohistochemistry 
Antibodies labeling synapses, dendrites, axons, and growth factors were used to assess 
tissue. Microtubule associated protein 2 (MAP2) was used to label dendrites. 
Synaptophysin is an integral membrane glycoprotein used to label synapses. 
Hypophosphorylated neurofilament, known as SMi32, was used to label axons due to its 
specificity for long-projection axons. Finally, growth associated protein 43 (GAP43) is a 
growth factor that was used to label potential growth cones and actively sprouting axons. 
All assays were batched processed using half of a series of spinal cord tissue from each 
animal. Tissue was simultaneously assimilated to room temperature and rinsed in tris 
buffered saline. Sections were then incubated in a blocking solution consisting of 10% 
normal goat serum, 1M glycine, and 0.4% triton for two hours. Following tissue was 
incubated in the primary antibody (1:500 MAP2 abcam; 1:500 Synaptophysin abcam; 
1:500 GAP43 millipore; 1:1k SMI32 abcam) with 5% normal goat serum and 0.4% triton 
overnight at room temperature. The next day tissue was rinsed and incubated with the 
corresponding secondary antibodies (Alexa Fluors Invitrogen) and 0.4% triton in the dark 
for two hours. Finally sections were rinsed and mounted immediately onto microscope 
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slides and allowed to dry for a few hours in the dark. Slides were then coverslipped with 
aquamount and left at room temperature in the dark for 36 hours before being imaged.  
Image Analysis 
A Leica TCS SPE laser scanning confocal microscope (Buffalo Grove, IL) was used to 
visualize fluorescence and acquire images for analysis. Eight sections from each animal 
were used for quantification. Tissue was co-labeled with either MAP2 and Synaptophysin 
or SMi32 and GAP43. Confocal z-stacks were taken using a 20X/0.75 objective lens with 
a 2x zoom of each animal in the ventral horn, dorsal horn, CST, or center region of the 
cervical spinal cord (Fig. 2). FIJI software (version 1.51i, National Institutes of Health) 
was used to open Z-stack images contained in .LIF files and conduct analyses of each 
stack. Percent Area was assessed for all individual markers. Specifically, images were 
split into individual channels and z-projected onto a 2D plane. Background was 
subtracted from 2D images before they were then run through the FIJI measurements 
tool. SMi32 images were further processed with a threshold using the default method and 
converted to binary masks. Masks were then run through the FIJI particle analysis tool to 
automatically count the cross-sectional axon profiles in the CST and used to estimate 
axon density. To assess the amount of synapses on lower motor dendrites, MAP2 and 
Synaptophysin co-labeled z-stacks of the ventral horn were split into two channels and 
run through the FIJI Coloc2 tool. The manders colocalization coefficient were used for 
analysis. Additionally, to assess axonal sprouting the same process was used for GAP43 
and SMi32 co-labeled z-stacks of the CST and center region. 
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Figure 2: Regions of Interest. Cross section of cervical spinal cord showing regions 
where images were taken for each individual ROI in this study. The corticospinal 
tract (CST), center region (CNTR), dorsal horn (DH), and ventral horn (VH). 
Statistics 
R Studio was used to run all statistical analyses. Percent area, axon density, and 
colocalization coefficients of each marker and ROI was first run through a three-way 
mixed ANOVA with between factors  “group” (treated, untreated) and “age”, and within 
subject factor “hemisphere side” (ipsilesional, contralesional). If there was no main effect 
of hemisphere side the within subject variable was separated and post-hoc tests of either 
contralesional or ipsilesional outcomes were run to assess differences between treated 
and untreated groups. If no interactions with age were noted Post-Hoc Student T-Tests 
were used to assess the group difference. When applicable Two-way ANOVAs with 
CST
CNTR
DH
VH
VH
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factors “group” and “age” and Post-Hoc Tukey Tests were used to account for significant 
interactions. Additionally, all outcomes were run through a multiple linear regression 
model against behavioral end points and age to assess associations with functional 
recovery.  
RESULTS 
Effects of MSCd Exosomes on Axons in the Cervical Spinal Cord 
A three-way ANOVA comparing axon density in the corticospinal tract (Figure 3A) with 
the between factors “group” and “age” and the within subject factor “hemisphere side” 
showed a trend towards a significance between hemispheres (F(6,1)= 5.802, p=0.053), no 
significant difference between groups (F(6,1)= 0.012, p=0.916), and significant 
interactions between side and age (F(6,1)=9.375, p=0.022). Post-Hoc Two-way ANOVA 
comparing untreated axon density to the between factor “age” and the within subject 
factor “hemisphere side” shows no significant difference between side (F(6,1)=0.330, 
p=0.586), no significant effect of age (F(6,1)=0.022, p=0.887), and no interactions 
(F(6,1)=0.183, p=0.684). Post-Hoc Two-way ANOVA comparing treated axon density to 
the between factor “age” and the within subject factor “hemisphere side” shows no 
significant difference between side (F(6,1)=1.670, p=0.244), a significant effect of age 
(F(6,1)=14.436, p=0.009), and a significant interaction (F(6,1)=8.382, p=0.028). 
Although there was not a significant difference, there was a trend in both groups that the 
ipsilesional CST has an increased axon density compared to the contralesional tract as 
would be expected following a cortical injury to primary motor cortex. 
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A three-way ANOVA comparing SMi32 percent area in the corticospinal tract (Figure 
3B) with between factors “group” and “age”, and the within subject factor  
as“hemisphere side” showed a significant difference between hemispheres (F(6,1)= 
7.018, p=0.038), no significant difference between groups (F(8,1)= 0.028, p=0.872), no 
significant effect of age (F(6,1)=2.670, p=0.153), and a significant interaction between 
hemisphere side and age (F(6,1)=18.358, p=0.005). Post-Hoc two-way ANOVA 
comparing SMI32 percent area in untreated animals to the between factor “age” and 
within subject factor “hemisphere side” shows no main effect of hemisphere side 
(F(6,1)=0.156, p=0.707), a significant effect of age (F(6,1)=12.085, p=0.013), and no 
interactions (F(6,1)=0.696, p=0.436). Post-Hoc two-way ANOVA comparing SMI32 
percent area in treated animals to the between factor “age” and within subject factor 
“hemisphere side” shows no main effect of hemisphere side (F(6,1)=0.010, p=0.924), no 
significant effect of age (F(6,1)=1.295, p=0.299), and no interactions (F(6,1)=0.637, 
p=0.455). 
A two-way ANOVA comparing SMi32 percent area in the center region of the cervical 
spinal cord  (Figure 3C) with between factors “group” and “age” showed no significant 
difference between groups (F(6,1)=0.811, p=0.403), no significant effect of age 
(F(6,1)=0.594, p=0.470), and no interactions (F(6,1)=1.614, p=0.251). 
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Figure 3: Axonal Changes in the CSC. Graphs of axon density (A) and SMi32 
percent area staining (B, C) in the CST or center region show no significant changes 
between groups or hemisphere. Axon density was calculated using the cross 
sectional profiles of the CST.  
Here we see no changes in SMi32 staining in either the CST or center region; however, 
there is a trend that the contralesional CST has a lower axon density. 
Effects of MSCd Exosomes on Sprouting Axons in the Cervical Spinal Cord 
In order to assess whether axons in the CSC were actively sprouting the growth factor, 
GAP43 was colocalized on SMi32 to look for axons expressing growth cones. The 
manders coefficient output from the Coloc-2 tool on Image J was used to analyze percent 
overlap for each marker. Manders 1 (M1) coefficient represents the percent of GAP43 
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that overlaps with SMi32, while the Manders 2 (M2) coefficient represents the percent of 
SMi32 that overlaps with GAP43. 
A three-way ANOVA comparing M1 coefficienct in the corticospinal tract (Figure 4A) 
with between factors as “group” and “age”, and within subject factors “hemisphere side” 
showed no significant difference between sides (F(6,1)=3.249, p=0.122), no significant 
effect of age (F(6,1)= 0.086, p=0.779), no significant differences between groups 
(F(6,1)=0.245, p=0.638), and no interactions (F(6,1)=1.724, p=0.237).  A three-way 
ANOVA comparing M2 coefficienct (Figure 4B) with between factors as “group” and 
“age”, and within subject factors  as “hemisphere side” showed a significant difference 
between sides (F(6,1)=8.662, p=0.026), no significant effect of age (F(6,1)= 0.390, 
p=0.555), no significant differences between groups (F(6,1)=0.001, p=0.988), and no 
interactions (F(6,1)=1.141, p=0.326). Post-Hoc Student t-tests of the M2 coefficient 
against hemisphere in the untreated animals showed a significant increase of GAP43 and 
SMi32 overlap in the ipsilesional tract (T(7)=4.26, p=0.013). Post-Hoc Student t-tests of 
the M2 coefficient against hemisphere in the treated animals shows no significant effect 
(T(7)=0.981, p=0.382). 
In the center region of the CSC, a two-way ANOVA comparing the M1 coefficient 
(Figure 4C) to between factors “group” and “age” shows no significant difference 
between groups (F(6,1)=0.292, p=0.608), no significant effect of age (F(6,1)=0.534, 
p=0.489), and no interactions (F(6,1)=1.303, p=0.297). A two-way ANOVA comparing 
the M2 coefficient (Figure 4D) to between factors “group” and “age” shows no 
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significant difference between groups (F(6,1)=0.276, p=0.618), no significant effect of 
age (F(6,1)=0.015, p=0.905), and no interactions (F(6,1)=0.953, p=0.367). 
 
 
Figure 4: Changes in Sprouting Axons. Graphs show the colocalization co-efficient 
of GAP43 overlapping with SMi32 (M1) and the colocalization co-efficient of SMi32 
overlapping with GAP43 (M2) in the CST and center region of exosome treated and 
untreated control animals. ANOVA and post-hoc TTests show the ipsilesional CST 
in untreated control animals have significantly more GAP43+ axons (T(7)=4.26, 
p=0.013) compared to exosome treated animals, suggesting more active sprouting.  
Here we show that in untreated animals the ipsilesional CST has significantly more 
sprouting axons than treated animals. 
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Effect of MSCd Exosomes on Dendrites in the Cervical Spinal Cord 
A three-way ANOVA comparing MAP2 percent area in the ventral horn (Figure 5A) 
with  between factors “group” and “age”, and the within subject factor “hemisphere side” 
showed no significant difference between hemispheres (F(6,1)=0.013, p=0.913), no 
significant effect of age (F(6,1)=5.494, p=0.056), a significant group difference 
(F(6,1)=24.809 p=0.0025) and no interactions (F(6,1)=0.217, p=0.658).  Post-Hoc 
Student t-tests of the contralesional MAP2 percent area between groups revealed that 
treated monkeys had significantly more MAP2 staining (T(4)=-2.839, p=0.025). Post Hoc 
Student T-Tests of the ipsilesional MAP2 percent area between groups also showed a 
significant increase of MAP2 percent area in the treated monkeys (T(4)= -4.117, 
p=0.003).  
A three-way ANOVA comparing MAP2 percent area in the dorsal horn (Figure 5B) with 
the between factors “group” and “age”, and the within subject factor “hemisphere side” 
showed no significant difference between hemispheres (F(6,1)=0.918, p=0.375), no 
significant effect of age (F6,1)=0.122, p=0.739), almost a significant group difference 
(F(6,1)= 5.873, p=0.052) and no interactions (F(6,1)=3.298, p=0.119).  
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Figure 5: Dendritic Changes in the CSC. Graphs represent the amount of MAP2 
percent area staining in the ventral or dorsal horns in both exosome treated and 
untreated control animals. ANOVA and post-hoc TTests reveal there is a significant 
increase of MAP2 staining in the exosome treated animals in both the contralesional 
(T(4)=-2.839, p=0.025) and ipsilesional (T(4)= -4.117, p=0.003) dorsal horns, which 
may suggest more dendrite arborization and plasticity. 
We find a significant increase in the amount of MAP2 staining in the treated animals on 
the ipsilesional and contralesional ventral horn suggesting increased dendrite plasticity. 
Effect of MSCd Exosomes on Synapses in the Cervical Spinal Cord 
A three-way ANOVA comparing synaptophysin percent area in the ventral horn (Figure 
6A) with the between factors “group” and “age”, and the within subject factor 
“hemisphere side” showed no significant difference between hemispheres (F(6,1)= 0.047, 
p=0.838), a significant effect of age (F(6,1)=12.014, p=0.013), no significant differences 
between groups (F(6,1)= 1.071, p=0.341), and no interactions (F(6,1)=0.001, p=0.989).   
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A three-way ANOVA comparing synaptophysin percent area in the dorsal horn (Figure 
6B) with the between factors “group” and “age”, and the within subject factor 
“hemisphere side” showed no significant difference between hemispheres (F(6,1)= 0.078, 
p=0.790), no significant effect of age (F(6,1)=0.339, p=0.581), no significant difference 
between groups (F(6,1)= 0.183, p=0.684), and no interactions (F(6,1)=0.067, p=0.804).  
 
Figure 6: Synaptic Changes in the CSC. Graphs denote the amount of 
synaptophysin percent area staining (A,B)  and MAP2+ synapses (C,D) in the 
ventral and dorsal horns of exosome treated and untreated control animals. M1 
represents the colocalization co-efficient of synaptophysin overlapping with MAP2, 
while M2 represents the colocalization co-efficient of MAP2 overlapping with 
synaptophysin. ANOVA and post-hoc TTests show there is significantly more 
synaptophysin overlapping with MAP2 in the untreated control animals in the 
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contralesional ventral horn compared to exosome treated animals (T(6)=-3.608, 
p=0.009). This suggests treated animals have fewer MAP2+ synapses. 
There are no differences in overall synaptophysin staining in either the ventral or dorsal 
horns.  
In order to assess whether somas and dendrites of the LMNs gained more synapses in the 
CSC synaptophysin was colocalized on MAP2. The manders coefficient output from the 
Coloc-2 tool on Image J was used to analyze percent overlap for each marker. Manders 1 
(M1) coefficient represents the percent of synaptophysin that overlaps with MAP2, while 
the Manders 2 (M2) coefficient represents the percent of MAP2 that overlaps with 
synaptophysin. 
ANOVAs were used to compare M1 or M2 coefficient of synaptophysin and MAP2 
overlap in the ventral horn three-way with the between factors “group” and “age”, and 
the within subject factor “hemisphere side”. ANOVA of M1 (Figure 6C) showed no 
significant difference between hemispheres (F(6,1)= 0.092, p=0.771), no significant 
effect of age (F(6,1)=1.654, p=0.246), a significant group difference (F(6,1)= 12.495, 
p=0.012), and no interactions (F(6,1)=0.027, p=0.876). Post-Hoc Student t-tests 
comparing contralesional M1 to groups showed that treated monkeys have significantly 
less overlap of synaptophysin to MAP2 (T(6)=-3.608, p=0.009) than untreated monkeys. 
Post-Hoc Student TTests comparing ipsilesional M1 to groups showed no significant 
differences (T(6)=-1.932, p=0.092). ANOVA of M2 (Figure 6D) showed no significant 
difference between hemispheres (F(6,1)= 0.594, p=0.470), no significant effect of age 
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(F(6,1)=0.171, p=0.694), no significant group difference (F(6,1)= 3.273, p=0.120), and 
no interactions (F(6,1)=0.301, p=0.603). 
We show that treated animals have significantly fewer MAP2+ synapses in the 
contralesional ventral horn. 
Associations between Axons and Behavioral Outcomes 
For the CST a multiple linear regression model was used to correlate the contralesional 
SMi32 percent area with age, grasp assessment outcomes (days to return to pre-operative 
grasp and mean grasp scores during the final week), and latency outcomes (days to return 
to pre-operative latency and retrieval latency during the final week) revealed no 
significant correlation (R=-0.227 p=0.672). A multiple linear regression model was used 
to correlate the ipsilesional SMi32 percent area with age, grasp assessment outcomes, and 
retrieval latency outcomes showed no significant correlation (R=0.060, p=0.560).  
For the CST a multiple linear regression model was used to correlate the contralesional 
axon density with age, grasp assessment outcomes (days to return to pre-operative grasp 
and mean grasp scores during the final week), and latency outcomes (days to return to 
pre-operative latency and retrieval latency during the final week) showed no significant 
correlation (R=0.692, p=0.220). A multiple linear regression model was used to correlate 
the ipsilesional axon density with age, grasp assessment outcomes, and retrieval latency 
outcomes showed no significant correlation (R=0.467, p=0.357).  
For the center region, a multiple linear regression model was used to correlate the SMi32 
percent area (Figure 7) with age, grasp assessment outcomes (days to return to pre-
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operative grasp and mean grasp scores during the final week), and latency outcomes 
(days to return to pre-operative latency and retrieval latency during the final week) shows 
a significant correlation (R=0.998, p=0.002) (Figure 7). Specifically, SMi32 staining 
negatively correlates with well 1 retrieval latency (p=0.002), well 2 retrieval latency 
(p=0.002), and age (p<0.001). 
 
Figure 7: Associations with Center Axon Staining. Multiple linear regression models 
reveal SMi32 percent area staining is significantly associated with retrieval latencies 
in both well 1 (R=0.1167, p=0.002) (A) and well 2 (R=0.0901, p=0.002) (B) as well as 
with age (R=0.0899, p<0.001) (C).  
Here we show increased SMi32 staining in the center region correlates with faster 
retrieval times and the amount of SMi32 staining in the center region decreases slightly 
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with age. Although statistically significant, the models account for very little of the 
variability. 
Associations between Sprouting Axons and Behavioral Outcomes 
For the CST multiple linear regression models were used to correlate the contralesional 
M1 or M2 coefficient with age, grasp assessment outcomes (days to return to pre-
operative grasp and mean grasp scores during the final week), and retrieval latency 
outcomes (days to return to retrieval latency and retrieval latency during the final week). 
Models revealed no significant correlation between behavioral outcomes and M1 (R=-
0.80, p=0.832) or M2 coefficients (R=-1.960, p=0.977). Multiple linear regression 
models were run to correlate the ipsilesional M1 or M2 with age, grasp assessment 
outcomes, and retrieval latency outcomes. Models reveal no significant correlation 
between measures of recovery and M1 (R=-0.281, p=0.690) or M2 (R=0.556, p=0.303).  
For the center region, multiple linear regression models were used to correlate the M1 or 
M2 coefficient with age, grasp assessment outcomes (days to return to grasp and mean 
grasp scores during the final week), and retrival latency outcomes (days to return to 
retrieval latency and retrieval latency for each well during the final week). Models 
revealed no significant correlation between behavioral outcomes and M1 (R=-1.195, 
p=0.904) or M2 coefficients (R=0.033, p=0.571).  
There are no associations between sprouting axons and behavioral outcomes. 
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Associations between Dendrites and Behavioral Outcomes 
For the Ventral horn, a multiple linear regression model to correlate the contralesional 
MAP2 percent area with age, grasp assessment outcomes (days to return to grasp, mean 
grasp scores during week 1 of testing, and mean grasp scores during the final week) and 
retrieval latency outcomes (days to return to retrieval latency, retrieval latency for each 
well during the first week of testing, retrieval latency for each well during the final week) 
showed no significant correlations (R=0.665, p=0.238). A multiple linear regression 
model to correlate the ipsilesional MAP2 percent area with age, grasp assessment 
outcomes (days to return to grasp and mean grasp scores during the final week) and 
retrieval latency outcomes (days to return to retrieval latency and retrieval latency for 
each well during the final week) shows no significant correlations (R=0.784, p=0.158). 
For the dorsal horn, a multiple linear regression model was used to correlate the 
contralesional MAP2 percent area with age, grasp assessment outcomes (days to return to 
grasp and mean grasp scores during the final week), and retreival latency outcomes (days 
to return to retrieval latency and retreival latency for each well during the final week) 
showed a trend towards a significant correlation (R=908, p=0.070). A multiple linear 
regression model was used to correlate the ipsilesional MAP2 percent area with age, 
grasp assessment outcomes, and retrieval latency outcomes shows no significant 
correlations (R=0.653, p=0.245).  
There are no associations between MAP2 staining and behavioral outcomes. 
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Associations between Synapses and Behavioral Outcomes 
For the ventral horn, a multiple linear regression model was used to correlate the 
contralesional synaptophysin percent area with age, grasp assessment outcomes (days to 
return to grasp and mean grasp scores during the final week), and retreival latency 
outcomes (days to return to retreival latency and retrieval latency during the final week) 
showed no significant correlation (R=0.413, p=0.387). A multiple linear regression 
model was used to correlate the ipsilesional synaptophysin percent area with age, grasp 
assessment outcomes, and retrieval latency outcomes showed no significant correlations 
(R=-0.018, p=0.593). 
 For the ventral horn, multiple linear regression models were used to correlate the 
contralesional M1 or M2 coefficient of synaptophysin and MAP2 with age, grasp 
assessment outcomes (days to return to grasp and mean grasp scores during the final 
week), and retrieval latency outcomes (days to return to retrieval latency and retreival 
latency during the final week). The models showed no significant correlation between 
measures of recovery and M1 (R=0.404, p=0.392) or M2 (R=0.724, p=0.199). Multiple 
linear regression models were used to assess correlatations between the ipsilesional M1 
or M2 coefficient of synaptophysin and MAP2 with age, grasp assessment outcomes, and 
retreival latency outcomes. The models showed no significant correlation between 
behavioral outcomes and M1 (R=0.086, p=0.548), but a significant correlation with M2 
(R=0.985, p=0.011) (Figure 8). Specifically, ipsilesional M2 coefficient positively 
correlated with age (p=0.044) and well 2 retrieval latency (p=0.011). Although it did not 
hold up to multiple regression analyses, there was a significant positive correlation 
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between the contralesional M1 coefficient and the well 1 (R=0.479, p=0.027) and well 2 
retrieval latencies (R=0.440, p=0.036). 
For the dorsal horn, a multiple linear regression model was used to correlate the 
contralesional synaptophysin percent area with age, grasp assessment outcomes (days to 
return to grasp and mean grasp scores during the final week), and retrieval latency 
outcomes (days to return to retrieval latency and retrieval latency during the final week) 
showed no significant correlation (R=0.589, p=0.285). A multiple linear regression 
model was used to correlate the ipsilesional synaptophysin percent area with age, grasp 
assessment outcomes, and retrieval latency outcomes shows an almost significant 
correlation (R=0.931, p=0.053).  
Figure 8: Associations with MAP2+ synapses. Graphs show that the manders co-
efficient of MAP2 overlapping with synaptophysin (M2) and of synaptophysin 
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overlapping with MAP2 (M1) in the ipsilesional (A,B) or contralesional (C,D) 
ventral horn. We used a multiple linear regression model to show ipsilesional M1 is 
associated with well 2 retrieval latency (R=0.4482, p=0.011) and age (R=0.3329, 
p=0.044). While panels C and D did not hold up in a multiple linear regression 
analyses, a single linear regression model denotes that contralesional M2 is 
associated with well 1 (R=0.479, p=0.027) and well 2 (R=0.440, p=0.036) retrieval 
latencies.  
We reveal that having fewer MAP2+ synapses in the ipsilesional and contralesional 
ventral horn correlated with faster retrieval times. Although the number of MAP2+ 
synapses in the ipsilesional ventral horn increased with age. 
DISCUSSION 
In this study we investigated the efficacy of MSCd exosomes to enhance the plasticity of 
LMNs in the CSC after cortical injury to the motor cortex in the NHP. Our previous 
study notes that treated monkeys display an early significant recovery during the first few 
weeks after injury and a full return to pre-operative retrieval latencies and grasp ratings 
without any signs of compensatory functions (Moore et al, Under Review). In the present 
study, histological examination of the CSC 14 weeks after injury revealed that exosomes 
1) significantly reduced the amount of axonal sprouts in the ipsilesional CST 2) increased
dendritic staining in both contralesional and ipsilesional ventral horns and 3) reduced the 
amount of MAP2+ synapses in the contralesional ventral horn. Additionally, reduced 
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MAP2+ synapses correlated with improved retrieval latencies suggesting that the 
physiological effects of exosomes played a role in recovery. 
Pathophysiology of Cortical Injury and Exosomes 
After cortical injury there is an increase in oxidative stress and pro-inflammatory 
processes leading to apoptosis within the lesion (Lipton et al., 1999). However, the 
increase in inflammatory cytokines and ROS can further lead to secondary damage of 
surrounding neurons (Patel et al., 2013; Fumagalli et al., 2015). Eventually, anti-
inflammatory processes promote cortical plasticity and phagocytosis of debris to enhance 
recovery of function (Carmichael et al., 2003; Nudo et al., 2007).  
Our previous study showed that MSCd exosome treated animals have a robust recovery 
during the first 2-4 weeks after injury, while untreated animals take up to 12 weeks to 
regain function (Moore et al, Under Review). Moreover, treated monkeys return to pre-
operational retrieval latency and grasp patterns, while untreated monkeys do not recover 
pre-operative retrieval latencies and typically develop compensatory grasp patterns. This 
suggests that MSCd exosomes promote a recovery earlier in the post-injury period either 
by reducing proinflammatory signals to prevent secondary damage or promoting 
plasticity due to growth signals. This is in line with previous studies showing exosomal 
transfer of IFN-gamma from MSCs can suppress immune activity of peripheral immune 
cells and subsequently increase the level of anti-inflammatory cytokines (Di Trapani et 
al., 2016; Phinney et al., 2015; B. Zhang et al., 2014). Further, MSCd exosomes also 
contain growth factors and miRNA that can promote angiogenesis and plasticity 
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(Bonnans, Chou, &amp; Werb, 2014; Phinney &amp; Pittenger, 2017; Talwar &amp; 
Srivastava, 2014; Vrijsen et al., 2016; Ruppert et al., 2018). Therefore, we propose that 
promoting the switch to anti-inflammatory processes and encouraging plasticity may 
limit cellular damage to the motor cortex and allow for earlier recovery.  
Axonal Pruning 
After injury to the motor cortex, upper motor neurons die leaving permanent damage to 
the corticospinal tract and reduced signals to LMNs (Lipton et al., 1999). During 
recovery, plasticity in the cortex can occur to rebuild motor circuits (Carmichaelet al., 
2003; Nudo et al., 2007); however, the fine motor movements of the hand are highly 
dependent on Betz cells, large pyramidal neurons, that cluster in the somatotopic map and 
are particularly prevalent in the hand representation (Rivara et al., 2003). The long 
distance projections of the Betz neurons could be susceptible to damage during secondary 
injury and therefore prevent the recovery of fine motor movements. However plasticity in 
the CST and LMNs may compensate for the loss of Betz cells, as studies have reported 
the ipsilesional CST could branch axons that cross the midline to synapse with neurons in 
the de-enervated ventral horn (Wiessner et al., 2003; Weidner et al., 2001; Lee et al., 
2004; Zai et al., 2009). Since, MSCd exosomes have been show to induce axonal growth 
of cortical neurons (Zhang Y et al., 2017) we hypothesize that the treated animals may 
have an environment that promotes axonal sprouting in the CST. Although we did not 
observe a significant difference in the amount of axonal staining between groups in this 
study, we do show that untreated monkeys have significantly more actively sprouting 
axons co-labeled with the growth factor, GAP43, in the ipsilesional tract. However,  
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axonal pruning is also an important process in injury recovery (Bareyre et al., 2004; Lang 
et al., 2012; Chen et al., 2014; Luo et al., 2005; Riccomagno et al., 2015). The robust 
recovery of treated monkeys in the first few weeks after injury may be representative of 
high levels of axonal sprouting early in the recovery period. Hence, at the time of tissue 
harvest 14 weeks post-injury untreated monkeys may still be attempting to repair their 
motor networks, while the treated monkeys may have already made connections and gone 
through a pruning process. 
Ventral Horn Plasticity 
Although we know plasticity in the cortex can lead to improved recovery (Lambertsen, 
Finsen, & Clausen, 2018; Orczykowski et al., 2018; Stonesifer et al., 2017), plasticity of 
LMNs has also been shown to further improve function (Wiessner et al., 2003; Weidner 
et al., 2001; Lee et al., 2004; Zai et al., 2009). Specifically, interneurons partnered to de-
enervated LMNs have been shown to secrete trophic factors to induce and navigate 
sprouting fibers for reconnection (Courtine et al., 2008; Yamashita et al., 2017). In the 
present study we show that treated monkeys have significantly more MAP2 staining in 
the ventral horn of both hemispheres and could be representative of increased dendritic 
arborization and plasticity. Although we do not observe specific differences in 
synaptophysin staining, when we co-localize this synaptic marker to MAP2 we find 
significantly less overlap in treated animals in the contralesional ventral horn. This 
indicates that there are fewer MAP2+ synapses. Yet, increased dendritic staining in the 
ventral horn, could be due to growth factors released from MSCd exosomes since both 
hemispheres show significantly increased staining (Bonnans, Chou, & Werb, 2014; 
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Phinney & Pittenger, 2017; Talwar & Srivastava, 2014; Vrijsen et al., 2016; Ruppert et 
al., 2018). The reduced overlap of synapses could simply be a result of varying levels of 
dendrite staining between groups. However, we report that fewer MAP2+ synapses in the 
ventral horn correlates with faster retrieval times suggesting a functional role. Since we 
see fewer sprouting axons in the treated animals, a decrease in MAP2+ synapses could 
further suggest that reduced damage to the cortex and earlier recovery processes may 
prevent the need for new connections in the ventral horn. Additionally, during the 
recovery process excess axon collaterals are pruned (Bareyre et al., 2004; Lang et al., 
2012), which is believed to be an important step for effectively reorganizing neural 
circuits (Chen et al., 2014; Luo et al., 2005; Riccomagno et al., 2015). As shown in 
Nakanishi et al. (2019), when the pruning processes were blocked in rodent models after 
central nervous system injuries, motor recovery was impaired. Hence, early recovery in 
exosome treated animals may have also led to more effective pruning processes that 
resulted in fewer synapses and a more efficiently re-organized motor circuit. Therefore, 
fewer MAP2+ synapses may be a result of reduced cortical damage and more effective 
pruning processes. 
Conclusion 
The consequences of cortical injury after an ischemic stroke can lead to long lasting 
disability and loss of fine motor function. Although there are treatments to remove 
blockages in vessels that cause ischemic strokes (Koroshetz, 1996), there are currently no 
FDA approved treatments to improve neural recovery after injury. In this study, we aim 
to understand the role of MSCd exosomes in improving recovery after cortical injury to 
38 
the hand area of the primary motor cortex. Specifically, our previous studies report 
exosomes improve functional recovery as early as the first few weeks after the injury 
(Moore et al, Under Review). Additionally, all treated monkeys regained pre-operational 
grasp patterns and made a full recovery. Here we show this recovery is associated with 
fewer synaptic connections in the ventral horn of the CSC and with fewer axonal sprouts 
in the CST. This suggests that immune and growth signals from MSCd exosomes may 
promote a faster recovery after cortical injury reducing the need for new synaptic 
connections and inducing earlier pruning processes in the CSC. Due to the length of 
time after injury that the tissue was harvested, further investigation is needed to assess 
whether differences are a result of earlier recovery and reduced cortical damage. Overall, 
we demonstrated that MSCd exosomes are a potential therapeutic for increasing 
functional recovery and plasticity after cortical injury. 
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